NIPH
ONC

NN Investment Partners Holdings’s BeOne Medicines Ltd ONC Stock Holding History

NN Investment Partners Holdings’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$4.68M Buy
24,800
+7,700
+45% +$1.64M 0.03% 409
2021
Q4 		$4.63M Buy
17,100
+1,900
+13% +$642K 0.02% 424
2021
Q3 		$5.52M Buy
15,200
+2,600
+21% +$850K 0.03% 394
2021
Q2 		$4.32M Sell
12,600
-100
-0.8% -$33.1K 0.02% 432
2021
Q1 		$4.42M Buy
12,700
+1,300
+11% +$430K 0.03% 429
2020
Q4 		$2.94M Buy
11,400
+4,600
+68% +$1.27M 0.02% 463
2020
Q3 		$1.95M Buy
6,800
+100
+1% +$23.5K 0.01% 492
2020
Q2 		$1.26M Sell
6,700
-300
-4% -$48.8K 0.01% 577
2020
Q1 		$861K Sell
7,000
-800
-10% -$125K 0.01% 595
2019
Q4 		$1.29M Sell
7,800
-2,600
-25% -$432K 0.01% 569
2019
Q3 		$1.27M Buy
10,400
+1,800
+21% +$239K 0.01% 557
2019
Q2 		$1.07M Buy
+8,600
New +$1.09M 0.01% 592
2019
Q1 		– Sell
-3,217
Closed -$452K – 799
2018
Q4 		$452K Buy
+3,217
New +$427K ﹤0.01% 634

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

NN Investment Partners Holdings's ONC Position: Q1 2022 in Review

NN Investment Partners Holdings increased its BeOne Medicines Ltd (ONC) stake by 45% in Q1 2022, buying an estimated $1.64M and bringing the position to 24,800 shares worth $4.68M. The position accounts for 0.03% of the portfolio, ranked #409.

NN Investment Partners Holdings first reported a position in ONC in Q4 2018 and has held it in 13 quarters since. The position peaked at $5.52M in Q3 2021. 239 funds tracked by Wall St. Rank hold ONC as of Q1 2022.

  • NN Investment Partners Holdings held 24,800 shares of BeOne Medicines Ltd worth $4.68M as of Q1 2022.
  • NN Investment Partners Holdings bought 7,700 BeOne Medicines Ltd shares in Q1 2022, an estimated $1.64M.
  • BeOne Medicines Ltd made up 0.03% of NN Investment Partners Holdings's portfolio in Q1 2022, its #409 holding.
  • NN Investment Partners Holdings first reported a position in BeOne Medicines Ltd in Q4 2018 and has held it in 13 quarters since.
  • NN Investment Partners Holdings's BeOne Medicines Ltd position peaked at $5.52M in Q3 2021.
  • 239 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2022.

Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.